By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zymeworks 

540 – 1385 West 8th Avenue

Vancouver  British Columbia  V6H 3V9  Canada
Phone: 604-678-1388 Fax: 604-737-7077


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
The Fonds de solidarité FTQ Invests $4 Million In Zymeworks In Support Of Québec’s Health Sciences Sector 12/19/2014 11:20:49 AM
Zymeworks And Merck & Co. (MRK) Extend And Expand Bi-specific Antibody Therapeutics Collaboration 12/9/2014 2:16:29 PM
Zymeworks Announces Research Collaboration With Dr. Dennis J. Slamon And University of California, Los Angeles (UCLA) 11/25/2014 9:57:00 AM
Eli Lilly (LLY) Adds $375 Million To Zymeworks Partnership 10/23/2014 6:56:08 AM
CMC Biologics And Zymeworks Enter Into Agreement For Process Development And Clinical Manufacture Of Bi-Specific Antibody Product Candidate 9/3/2014 11:47:03 AM
Zymeworks Announces Strategic Collaboration With Eli Lilly and Company (LLY) Subsidiary ImClone Systems (LLY) To Develop Bi-specific Antibodies Using Zymeworks' Azymetric™ Platform 1/9/2014 8:13:24 AM
Zymeworks Wraps Up $15 Million Funding Round 1/9/2014 7:00:35 AM
Zymeworks Announces the Addition of Dr. Leonard Presta to its Scientific Advisory Board 8/15/2013 7:00:19 AM
Zymeworks to Receive an Undisclosed Amount From Merck & Co., Inc. (MRK), Part of a $187 Million Alliance 4/16/2013 7:14:07 AM
Zymeworks Raises $11 Million, Hits Antibody Drug Milestone for Merck & Co., Inc. (MRK) 9/6/2012 7:57:01 AM
123
//-->